MREO · NASDAQ
Mereo BioPharma Group (MREO) Stock Price & Fundamentals
Mereo BioPharma Group (MREO) closed at $649.04 on Oct 9, 2026, up 0.24% from the previous close of $647.47.
Share price, past year
1Y +1.58%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $649.04 |
| Sep 30, 2026 | $642.21 |
| Aug 31, 2026 | $644.75 |
| Jul 31, 2026 | $639.56 |
| Jun 30, 2026 | $635.89 |
| May 29, 2026 | $641.19 |
| Apr 30, 2026 | $622.99 |
| Mar 31, 2026 | $593.53 |
| Feb 27, 2026 | $606.38 |
| Jan 30, 2026 | $613.78 |
| Dec 31, 2025 | $590.21 |
| Nov 28, 2025 | $605.03 |
| Oct 31, 2025 | $643.94 |
Key statistics
- Market cap
- $518.23B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.03
- Revenue (TTM)
- —
- Net income (TTM)
- −$28.10M
- Shares outstanding
- 798.5M
- Dividend yield
- —
- 52-week range
- $565.62 – $654.69
Mereo BioPharma Group's market cap is $518.23B, based on a share price of $649.04 and 798.5M shares outstanding as of Aug 7, 2026.
Financials
Mereo BioPharma Group reported revenue of $500.00K for fiscal 2025.
Mereo BioPharma Group reported a net loss of $41.88M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $500.00K | — | −$41.88M | −8,375.6% | −$0.05 | −$30.99M |
| FY2024ended Dec 31, 2024 | $0.00 | −100.0% | −$43.25M | — | −$0.06 | −$32.83M |
| FY2023ended Dec 31, 2023 | $10.00M | — | −$29.47M | −294.7% | −$0.04 | −$21.13M |
| FY2022ended Dec 31, 2022 | $0.00 | — | −$42.22M | — | −$0.07 | −$48.83M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $0.00 | −$7.01M | −$0.01 |
| Q3 FY2025ended Sep 30, 2025 | $0.00 | −$7.02M | −$0.01 |
| Q2 FY2025ended Jun 30, 2025 | $500.00K | −$14.62M | −$0.02 |
| Q4 FY2024ended Dec 31, 2024 | $0.00 | −$7.05M | −$0.01 |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$15.00M | −$0.02 |
| Q2 FY2024ended Jun 30, 2024 | $0.00 | — | — |
| Q1 FY2024ended Mar 31, 2024 | $0.00 | — | — |
| Q4 FY2023ended Dec 31, 2023 | $1.00M | — | — |
Company profile
- Name
- Mereo BioPharma Group plc
- Ticker
- MREO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- One Cavendish Place, Fourth Floor, London, W1G 0QF
- Incorporated in
- X0
- Fiscal year ends
- December
- SEC CIK
- 0001719714
Recent SEC filings
- Aug 19, 2026
- Aug 11, 2026
- Aug 11, 2026
- Aug 11, 2026
- May 14, 2026
- May 12, 2026
- May 12, 2026
- Mar 27, 2026
Frequently asked questions
What is Mereo BioPharma Group's stock price?
Mereo BioPharma Group (MREO) closed at $649.04 on Oct 9, 2026, up 0.24% from the previous close of $647.47.
What is Mereo BioPharma Group's market cap?
Mereo BioPharma Group's market cap is $518.23B, based on a share price of $649.04 and 798.5M shares outstanding as of Aug 7, 2026.
How much revenue does Mereo BioPharma Group make?
Mereo BioPharma Group reported revenue of $500.00K for fiscal 2025.
Does Mereo BioPharma Group pay a dividend?
Mereo BioPharma Group's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Mereo BioPharma Group plc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures